SPAG5 and prostate carcinoma: In other cancer types, the SPAG5 expression and function were also correlated with miRNAs, such as miR-1179 in non-small cell lung cancer [34], miR-539 in prostate cancer [6] and miR-363-3p in hepatocellular cancer [14].